Pixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/Refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide in MSS Metastatic Colorectal Carcinoma (mCRC)
Clinical trial NCT05061017 · COMPLETED
Trial details
- NCT number
- NCT05061017
- Sponsor
- Diwakar Davar
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-09
- Primary completion
- 2024-02-05
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.